Effect of Mobile Health Applications on Improving Self-Management Knowledge and Seizure Control in Epilepsy Patients: A Scoping Review

키워드

참고문헌 (62)

1. Cascino GC, "Epilepsy" (2021), John Wiley & Sons
2. Aminoff M, "Current medical diagnosis & treatment", pp.970~1045 (2023), Mc-Graw Hill Education
3. "Epilepsy" (2024)[URL]
4. Nwani PO, "Patterns of antiepileptic drug use and seizure control among people with epilepsy in a suburban community in Southeast Nigeria", Afr J Neurol Sci, 31(2), pp.36~42 (2012)
5. Bonnett LJ, "Time to 12-month remission and treatment failure for generalised and unclassified epilepsy", J Neurol Neurosurg Psychiatry, 85(6), pp.603~610 (2014)[DOI]
6. Faught RE, "Impact of nonadherence to antiepileptic drugs on health care utilization and costs : findings from the RANSOM study", Epilepsia, 50(3), pp.501~509 (2009)[DOI]
7. Lie IA, "Treatment non-adherence as a trigger for status epilepticus : an observational, retrospective study based on therapeutic drug monitoring", Epilepsy Res, 113, pp.28~33 (2015)[DOI]
8. Firmawati E, "Mobile health application to support family caregivers in recurrent stroke prevention : scoping review", Open Access Maced J Med Sci, 9(T5), pp.142~151 (2021)[DOI]
9. Volpi SS, "Using a mobile health app to improve patients’ adherence to hypertension treatment : a nonrandomized clinical trial", PeerJ, 9, pp.e11491~ (2021)[DOI]
10. Peters MD, "Guidance for conducting systematic scoping reviews", Int J Evid Based Healthc, 13(3), pp.141~146 (2015)[DOI]
11. Tricco AC, "PRISMA extension for scoping reviews(PRISMA-ScR) : checklist and explanation", Ann Intern Med, 169(7), pp.467~473 (2018)[DOI]
12. Le Marne FA, "EpApp : development and evaluation of a smartphone", tablet app for adolescents with epilepsy, 2018, pp.50, 214~220
13. Rajbhandari H, "Epilepsy field workers, a smartphone application and telephone telemedicine : safe and effective epilepsy care in rural Nepal", Seizure, 64, pp.54~58 (2019)[DOI]
14. Simblett SK, "Patient perspectives on the acceptability of mHealth technology for remote measurement and management of epilepsy : a qualitative analysis", Epilepsy Behav, 97, pp.123~129 (2019)[DOI]
15. Si Y, "Optimising epilepsy management with a smartphone application : a randomised controlled trial", Med J Aust, 212(6), pp.258~262 (2020)[DOI]
16. Mirpuri P, "The development and efficacy of a mobile phone application to improve medication adherence for persons with epilepsy in limited resource settings : a preliminary study", Epilepsy Behav, 116, pp.107794~ (2021)[DOI]
17. Choi SA, "Impact of mobile health application on data collection and self-management of epilepsy", Epilepsy Behav, 119, pp.107982~ (2021)[DOI]
18. Yoo S, "Developing a mobile epilepsy management application integrated with an electronic health record for effective seizure management", Int J Med Inform, 134, pp.104051~ (2020)[DOI]
19. Mohammadzadeh N, "Evaluation of m-health applications use in epilepsy : a systematic review", Iran J Public Health, 50(3), pp.459~469 (2021)[DOI]
20. Goldenholz DM, "Common data elements for epilepsy mobile health systems", Epilepsia, 59(5), pp.1020~1026 (2018)[DOI]
21. DiIorio C, "Results of a research study evaluating WebEase, an online epilepsy self-management program", Epilepsy Behav, 22(3), pp.469~474 (2011)[DOI]
22. Bautista RE, "Understanding the self-management skills of persons with epilepsy", Epilepsy Behav, 69, pp.7~11 (2017)[DOI]
23. Joshi R, "Adverse effects & drug load of antiepileptic drugs in patients with epilepsy : monotherapy versus polytherapy", Indian J Med Res, 145(3), pp.317~326 (2017)[DOI]
24. Obiako OR, "Factors affecting epilepsy treatment outcomes in Nigeria", Acta Neurol Scand, 130(6), pp.360~367 (2014)[DOI]
25. Fisher RS, "Instruction manual for the ILAE 2017 operational classification of seizure types", Epilepsia, 58(4), pp.531~542 (2017)[DOI]
26. Chaka A, "Determinants of depression among people with epilepsy in Central Ethiopia", Ann Gen Psychiatry, 17, pp.27~ (2018)[DOI]
27. Blixen C, "Correlates of stigma in people with epilepsy", J Clin Neurol, 16(3), pp.423~432 (2020)[DOI]
28. "Huber R, Weber P. Is there a relationship between socioeconomic factors and prevalence, adherence and outcome in childhood epilepsy? A systematic scoping review. Eur J Paediatr Neurol 2022;38 : 1-6"[URL]
29. Niriayo YL, "Treatment outcome and associated factors among patients with epilepsy", Sci Rep, 8(1), pp.17354~ (2018)[DOI]
30. Boon P, "Recommendations for the treatment of epilepsy in adult and pediatric patients in Belgium : 2020update", Acta Neurol Belg, 121(1), pp.241~257 (2021)[DOI]
31. Thompson ME, "User preferences for the design of a mobile health system to support transition-age youth with epilepsy", J Pediatr Health Care, 34(3), pp.e28~e36 (2020)[DOI]
32. Sibernagl S, "Color of atlas pathophysiology", pp.364~365 (2016), Thieme Publishers
33. Ikawati Z, , pp.89~115 (2018), Bursa Ilmu
34. Belayneh Z, "A systematic review and metaanalysis of anti-epileptic medication non-adherence among people with epilepsy in Ethiopia", Arch Public Health, 78, pp.23~ (2020)[DOI]
35. Ernawati I, "How to improve clinical outcome of epileptic seizure control based on medication adherence? A literature review", Open Access Maced J Med Sci, 6(6), pp.1174~1179 (2018)[DOI]
36. Zena D, "Seizure control and its associated factors among epileptic patients at Neurology Clinic, University of Gondar hospital, Northwest Ethiopia", SAGE Open Med, 10, pp.20503121221100612~ (2022)[DOI]
37. Ferrari CM, "Factors associated with treatment non-adherence in patients with epilepsy in Brazil", Seizure, 22(5), pp.384~389 (2013)[DOI]
38. Elsayed MA, "Factors affecting adherence to antiepileptic medications among Sudanese individuals with epilepsy : a cross-sectional survey", J Family Med Prim Care, 8(7), pp.2312~2317 (2019)[DOI]
39. Shegog R, "Managing epilepsy well : emerging e-tools for epilepsy self-management", Epilepsy Behav, 29(1), pp.133~140 (2013)[DOI]
40. Pandey DK, "Self-management skills and behaviors, selfefficacy, and quality of life in people with epilepsy from underserved populations", Epilepsy Behav, 98(Pt A), pp.258~265 (2019)[DOI]
41. Escoffery C, "A review of mobile apps for epilepsy self-management", Epilepsy Behav, 81, pp.62~69 (2018)[DOI]
42. Tang F, "The effects of medication education and behavioral intervention on Chinese patients with epilepsy", Epilepsy Behav, 37, pp.157~164 (2014)[DOI]
43. McKellar K, "Current research on sexual health and teenagers", pp.5~23 (2020), Academic Press
44. Michaelis R, "Cochrane systematic review and meta-analysis of the impact of psychological treatment on health-related quality of life in people with epilepsy : an update by the ILAE Psychology Task Force, highlighting methodological changes", Epileptic Disord, 23(6), pp.803~811 (2021)[DOI]
45. Falco-Walter JJ, "The new definition and classification of seizures and epilepsy", Epilepsy Res, 139, pp.73~79 (2018)[DOI]
46. Paschal AM, "Measures of adherence to epilepsy treatment : review of present practices and recommendations for future directions", Epilepsia, 49(7), pp.1115~1122 (2008)[DOI]
47. Beyene YB, "Drug therapy problems and predicting factors among ambulatory epileptic patients in Jimma Medical Center, Southwest Ethiopia", PLoS One, 17(4), pp.e0267673~ (2022)[DOI]
48. French JA, "Clinical practice. Initial management of epilepsy", N Engl J Med, 359(2), pp.166~176 (2008)[DOI]
49. Ayalew MB, "Patient reported adverse events among epileptic patients taking antiepileptic drugs", SAGE Open Med, 6, pp.2050312118772471~ (2018)[DOI]
50. Perucca P, "Adverse antiepileptic drug effects : toward a clinically and neurobiologically relevant taxonomy", Neurology, 72(14), pp.1223~1229 (2009)[DOI]
51. Peasah SK, "Association between adverse events and discontinuation of antiepileptic drugs among drug-naive adults with epilepsy", Drugs Real World Outcomes, 8(1), pp.5~14 (2021)[DOI]
52. Reis TM, "Contributions of pharmacists in the treatment of epilepsy : a systematic review", Am J Pharm Benefits, 8(3), pp.e55~e60 (2016)
53. Aliasgharpour M, "Effects of an educational program on selfmanagement in patients with epilepsy", Seizure, 22(1), pp.48~52 (2013)[DOI]
54. Wagner JL, "Self-management interventions in pediatric epilepsy : what is the level of evidence?", Epilepsia, 58(5), pp.743~754 (2017)[DOI]
55. Ozuna J, "Self-management in epilepsy care : untapped opportunities", Fed Pract, 35(Suppl 3), pp.S10~S16 (2018)
56. Singh S, "Myths and superstition about epilepsy : a study from North India", J Neurosci Rural Pract, 9(3), pp.359~362 (2018)[DOI]
57. Aljedaani B, "Challenges with developing secure mobile health applications : systematic review", JMIR Mhealth Uhealth, 9(6), pp.e15654~ (2021)
58. Zubaydi F, "Security of mobile health (mHealth) systems", Proceedings of 2015IEEE 15th International Conference on Bioinformatics and Bioengineering (BIBE), pp.1~5 (2015)
59. Lewis TL, "mHealth and mobile medical Apps : a framework to assess risk and promote safer use", J Med Internet Res, 16(9), pp.e210~ (2014)[DOI]
60. Moalong KM, "Treatment gaps and challenges in epilepsy care in the Philippines", Epilepsy Behav, 115, pp.107491~ (2021)[DOI]
61. Abreu M, "Mobile applications for epilepsy: where are we? where should we go? A systematic review", Signals, 3(1), pp.40~65 (2022)[DOI]
62. Patel J, "Use of an electronic seizure diary in a randomized, controlled trial of natalizumab in adult participants with drug-resistant focal epilepsy", Epilepsy Behav, 118, pp.107925~ (2021)[DOI]

관련 논문AI추천